Literature DB >> 16931820

An approach to model the costs and effects of case management of Plasmodium falciparum malaria in sub-saharan Africa.

Fabrizio Tediosi1, Nicolas Maire, Thomas Smith, Guy Hutton, Jürg Utzinger, Amanda Ross, Marcel Tanner.   

Abstract

An important shortcoming of existing methods for estimating the cost-effectiveness of malaria control interventions is that the incidence of illness and transmission dynamics are assumed to be independent of the case management system. We have developed a model for case management and integrated it into a stochastic simulation of Plasmodium falciparum malaria dynamics. This allows us to predict the incidence of clinical episodes and of mortality while incorporating effects of case management on persistence of parasites and transmission. We make predictions for a range of different transmission intensities in sub-Saharan Africa and simulate a range of case management scenarios with different coverage rates. The model predicts that high treatment rates have a proportionately greater epidemiologic impact at low transmission levels. Further development is needed for models for health-seeking behavior and referral patterns. The current model is a first step towards useful predictions of the epidemiologic and economic consequences of introducing and/or scaling-up of malaria control interventions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16931820     DOI: 10.4269/ajtmh.2006.75.90

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  37 in total

1.  Climate influences on the cost-effectiveness of vector-based interventions against malaria in elimination scenarios.

Authors:  Paul E Parham; Dyfrig A Hughes
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-04-05       Impact factor: 6.237

Review 2.  The state of health economic research in South Africa: a systematic review.

Authors:  Paul Gavaza; Karen L Rascati; Abiola O Oladapo; Star Khoza
Journal:  Pharmacoeconomics       Date:  2012-10-01       Impact factor: 4.981

Review 3.  Costs and cost-effectiveness of malaria control interventions--a systematic review.

Authors:  Michael T White; Lesong Conteh; Richard Cibulskis; Azra C Ghani
Journal:  Malar J       Date:  2011-11-03       Impact factor: 2.979

4.  A Cost-Effectiveness Analysis of Plasmodium falciparum Malaria Elimination in Hainan Province, 2002-2012.

Authors:  Ding-Wei Sun; Jian-Wei Du; Guang-Ze Wang; Yu-Chun Li; Chang-Hua He; Rui-De Xue; Shan-Qing Wang; Xi-Min Hu
Journal:  Am J Trop Med Hyg       Date:  2015-10-05       Impact factor: 2.345

5.  Interpreting malaria age-prevalence and incidence curves: a simulation study of the effects of different types of heterogeneity.

Authors:  Amanda Ross; Thomas Smith
Journal:  Malar J       Date:  2010-05-17       Impact factor: 2.979

6.  Modeling the human infectious reservoir for malaria control: does heterogeneity matter?

Authors:  Elsa Hansen; Caroline O Buckee
Journal:  Trends Parasitol       Date:  2013-04-15

7.  P. falciparum infection durations and infectiousness are shaped by antigenic variation and innate and adaptive host immunity in a mathematical model.

Authors:  Philip Eckhoff
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

8.  Simulation of the cost-effectiveness of malaria vaccines.

Authors:  Fabrizio Tediosi; Nicolas Maire; Melissa Penny; Alain Studer; Thomas A Smith
Journal:  Malar J       Date:  2009-06-08       Impact factor: 2.979

9.  Modelling the cost-effectiveness of mass screening and treatment for reducing Plasmodium falciparum malaria burden.

Authors:  Valerie Crowell; Olivier J T Briët; Diggory Hardy; Nakul Chitnis; Nicolas Maire; Aurelio Di Pasquale; Thomas A Smith
Journal:  Malar J       Date:  2013-01-03       Impact factor: 2.979

10.  A novel approach for measuring the burden of uncomplicated Plasmodium falciparum malaria: application to data from Zambia.

Authors:  Valerie Crowell; Joshua O Yukich; Olivier J T Briët; Amanda Ross; Thomas A Smith
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.